- Page 1 and 2: contra costa county emergency medic
- Page 3: A1 — Adult Patient Care A2 — Ch
- Page 6 and 7: A2-ADULT CHEST PAIN SUSPECTED ACUTE
- Page 8 and 9: A3-ADULT CARDIAC ARREST - INITIAL C
- Page 10 and 11: A4-ADULT VENTRICULAR FIBRILLATION P
- Page 12 and 13: A5-ADULT PULSELESS ELECTRICAL ACTIV
- Page 14 and 15: A6-ADULT SYMPTOMATIC BRADYCARDIA He
- Page 16 and 17: A7-ADULT VENTRICULAR TACHYCARDIA WI
- Page 18 and 19: A8-ADULT SUPRAVENTRICULAR TACHYCARD
- Page 20 and 21: A9-ADULT OTHER CARDIAC DYSRHYTHMIAS
- Page 22 and 23: A10-ADULT SHOCK / HYPOVOLEMIA HYPOV
- Page 24 and 25: A11-ADULT POST-CARDIAC ARREST CARE
- Page 29: G1 — Allergy and all patients G9
- Page 33 and 34: If serious progression of symptoms
- Page 35 and 36: Key Treatment Considerations • Na
- Page 37 and 38: CONSIDER CHEMICAL RESTRAINT MONITOR
- Page 39 and 40: Key Treatment Considerations • Ai
- Page 41 and 42: COMPLICATED DELIVERY BREECH DELIVER
- Page 43 and 44: G7-GENERAL ENVENOMATIONS (Bites/Sti
- Page 45 and 46: Key Treatment Considerations • Se
- Page 47 and 48: Key Treatment Considerations • Av
- Page 49 and 50: • Closed head injury • Altered
- Page 51 and 52: ORGANOPHOSPHATE POISONING Hypersali
- Page 53 and 54: Key Treatment Considerations SAFETY
- Page 55 and 56: NITROGLYCERIN CONSIDER MORPHINE SUL
- Page 57 and 58: Key Treatment Considerations • Mo
- Page 59 and 60: CINCINNATI STROKE SCALE If any one
- Page 61 and 62: INDICATIONS AND PRECAUTIONS FOR MOR
- Page 63 and 64: G16-GENERAL TRAUMA - EXTREMITY cons
- Page 65: CONSIDER ONDANSETRON For severe nau
- Page 70 and 71: P1-PEDIATRIC PEDIATRIC PATIENT CARE
- Page 72 and 73: P2-PEDIATRIC CARDIAC ARREST - INITI
- Page 74 and 75: P3-PEDIATRIC NEONATAL CARE AND RESU
- Page 76 and 77:
P4-PEDIATRIC VENTRICULAR FIBRILLATI
- Page 78 and 79:
P5-PEDIATRIC PULSELESS ELECTRICAL A
- Page 80:
P6-PEDIATRIC SYMPTOMATIC BRADYCARDI
- Page 83 and 84:
UNSTABLE SUPRAVENTRICULAR TACHYCARD
- Page 85:
Key Treatment Considerations Succes
- Page 89 and 90:
IFT 1-TRANSFER INTERFACILITY TRANSF
- Page 91:
IFT 3-TRANSFER INTERFACILITY TRANSF
- Page 96 and 97:
DESTINATION DETERMINATION - BASIC P
- Page 98 and 99:
GENERAL DESTINATION PRINCIPLES PATI
- Page 100 and 101:
BASE HOSPITAL DESTINATION DECISION
- Page 102 and 103:
OBVIOUS DEATH MEDICAL ARREST TRAUMA
- Page 104 and 105:
ABUSE REPORTING RESPONSIBILITIES EM
- Page 106 and 107:
RESTRAINT TYPES RESTRAINT ISSUES LA
- Page 108:
BACKGROUND SITE REQUIREMENTS PROCED
- Page 111 and 112:
HAZMAT RECOGNITION WHILE ON SCENE (
- Page 113:
ON-VIEWS • In the event that a no
- Page 117 and 118:
12-LEAD ACQUISITION AND LEAD PLACEM
- Page 119 and 120:
STEMI RECOGNITION STEMI REPORT DEST
- Page 121 and 122:
TRANSMISSION OF MONITOR DATA • 12
- Page 123 and 124:
AIRWAY POSITIONING Position the pat
- Page 125 and 126:
KEY PROCEDURES Skill Indication / C
- Page 127 and 128:
KEY PROCEDURES Skill Indication / C
- Page 129:
KEY PROCEDURES Skill Indication / C
- Page 132 and 133:
Oxygen Safety Initial Indications f
- Page 134 and 135:
PAIN ASSESSMENT AND MANAGEMENT Reli
- Page 136 and 137:
PEDIATRIC ASSESSMENT Begin interven
- Page 138 and 139:
PEDIATRIC MEDICATION ADMINISTRATION
- Page 140 and 141:
SEPSIS SCREENING • Sepsis is a li
- Page 142:
VASCULAR ACCESS Skill Indication /
- Page 145:
TREATMENT DESTINATION AND DISPOSITI
- Page 149 and 150:
TIER ZERO TIER ONE TIER TWO TIER TH
- Page 152 and 153:
SBAR REPORTING SBAR is a tool that
- Page 154 and 155:
EMT SCOPE OF PRACTICE (STATE REGULA
- Page 156 and 157:
PARAMEDIC SCOPE OF PRACTICE Califor
- Page 158:
PARAMEDIC SCOPE OF PRACTICE (contin
- Page 161 and 162:
Kaiser Medical Center - Antioch 500
- Page 163:
OUT-OF-COUNTY SPECIALTY CENTERS Hos
- Page 167 and 168:
ADULT DRUG REFERENCE Drug Indicatio
- Page 169 and 170:
ADULT DRUG REFERENCE Drug Indicatio
- Page 171 and 172:
NALOXONE ADULT DRUG REFERENCE Drug
- Page 173 and 174:
PEDIATRIC DRUG REFERENCE Drug Indic
- Page 176 and 177:
Yellow (12-14 kg) 2.7 mg 2nd - 0.9
- Page 178 and 179:
Assure adequate ventilation before
- Page 180 and 181:
Note: Cardioversion energy dosages
- Page 182 and 183:
Consider giving one-half dosage dip
- Page 184 and 185:
45 kg 0.3 mg 0.3 ml IM / SC 40 kg 0
- Page 186 and 187:
45 kg 1 mg 1 ml Green (30-36 kg) 1
- Page 188 and 189:
40 kg 4 mg 0.8 ml 45 kg 4.5 mg 0.9
- Page 190 and 191:
For patients 19 kg and above may ti
- Page 192 and 193:
45 kg 45 kg 101 lbs Green 30-36 kg
- Page 194:
0 0 1-2 MILD 1-2 LEVE PAIN RATING S